PACS Group, Inc. (NYSE: PACS) has entered into a definitive agreement to acquire certain assets from a portfolio of skilled nursing facilities, according to a June 2026 corporate filing. The …
Tag:
Healthcare
-
-
People living with dementia face a significantly higher risk of hospitalization and death during extreme temperature events compared to the general population, according to research published in the Journal of …
-
Chinese Probiotic Market Sees Rapid Growth, Sparks Interest from Global Players The Chinese probiotic market has expanded significantly, driven by rising consumer awareness of gut health and regulatory reforms, according …
-
Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes. According to the U.S. Food and Drug Administration (FDA), the medication …
-
Generative AI tools are moving from administrative tasks into direct clinical support, with a new study from Mass General Brigham examining how large language models (LLMs) assist primary care physicians …
-
FDA Approves Generic Oseltamivir Phosphate for Oral Suspension The U.S. Food and Drug Administration (FDA) has granted approval for a generic version of oseltamivir phosphate for oral suspension, 6 mg/mL, …
-
California Billionaire Tax Measure Moves to November Ballot Amid Political Battle California’s proposed billionaire tax measure, aimed at offsetting federal healthcare funding cuts, is set to appear on the November …
-
Health
Gyeonggi Northern Atopy & Asthma Center: Supporting Community Health for World Allergy Week 2026
Managing Chronic Allergic Diseases: Insights from Regional Education Centers Community-based support systems, such as the Gyeonggi Northern Atopy and Asthma Education Information Center, provide critical resources for patients managing chronic …
-
Combining Strength Training and Cardio Reduces Type 2 Diabetes Risk, Study Shows A study published in the Journal of the American Medical Association (JAMA) found that adults who engaged in …
-
Eli Lilly Announces Price Cut for Mounjaro Amid Cost-Effectiveness Debate Eli Lilly & Co. announced a significant price reduction for its diabetes drug Mounjaro in April 2024, according to a …